Nyxoid 1,8 mg, Nasenspray

7680669300012 CH-66930 Nasenspray

Associated product:

Nyxoid 1,8 mg, Nasenspray
Nyxoid 1,8 mg, Nasenspray
Nyxoid 1,8 mg, Nasenspray
Nyxoid 1,8 mg, Nasenspray
1 / 3
google

Article details

Package size
2
Selling units
2
Measure
Einzeldose(n)
Galenic form
Nasenspray
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/05/2025
Patient information leaflet
Français
16/05/2025
Patient information leaflet
Italien
16/05/2025
Summary of Product Characteristics
Allemand
16/05/2025
Summary of Product Characteristics
Français
16/05/2025
Summary of Product Characteristics
Italien
16/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.2 MG Substance WIZUS
(N/A)
2.0 MG Substance WIZUS
(N/A)
1.8 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance TRGAS
(N/A)
- Substance HNIDK
(N/A)
0.14 MG Substance HBESI

Authorization holder

Mundipharma Medical Company,

4052 Basel

Authorization information

Swissmedic authorization number
66930
Drug name
Nyxoid, Nasenspray
Galenic form
NASS
ATC Code
V03AB15
Authorization status
Z
Dispensing category
B
First authorization
12/07/2018
Authorization expiration date
31/12/9999
IT Number
15.01.1.
Domain
Human medicine
Field of application
Opioid-Antagonist

Package details

Description (FR)
NYXOID spray nasal 1.8 mg 2 x 1 dos
Description (DE)
NYXOID Nasenspray 1.8 mg 2 x 1 Dos
Narcotic (BTM)
No